MSB - Mesoblast Limited

[qldfrog]

Looks like a few companies going into financial trouble !

This one which could be considered big based on Market Cap and recently another spec OLI which is suspended having run out of money
In the process we get sliced up being the shareholders

Was supposed to be blacklisted for me since late last year. none of my systems sneaked it in.did check..
That company has already burnt enough of my money.?

 

[qldfrog]

@Knobby22 hope you did not give in and bought back in.one of your pet stock but i believe we can agree : great idea.concept but not a great company

 

[Knobby22]

@Knobby22 hope you did not give in and bought back in.one of your pet stock but i believe we can agree : great idea.concept but not a great company

I did buy a few back in early February at $2.69. Liked the fact the back pain therapy worked.
Own much less than I used to. Still think its worth keeping an eye on but its a biotech so you have to be nimble.
Some investor is going to buy in and probably get part of the company for a steal. Hopefully a US investor who can finally get these approvals happening.

Also still waiting for an SPL product to be approved despite the fact that every other country in the world has already approved it.

 

[UMike]

....... Still think its worth keeping an eye on but its a biotech so you have to be nimble.
......

Bought back in at 2.25.

Totally agree with the nimble statement.

Not a long term thing just a bit of opportunistic punting.

 

[UMike]

Mesoblast has entered into a license and collaboration agreement with Novartis for the development, manufacture, and commercialization of remestemcel-L, with an initial focus on the treatment of acute respiratory distress syndrome (ARDS), including that associated with COVID-19. The agreement remains subject to certain closing conditions, including time to analyze the results from this COVID-19 ARDS trial

Enough to have a punt in the tipping comp.

Have an unfulfilled buy order at 1.865.
I expect it to remain unfulfilled and make me suffer as it climbs back of the canvas.

 

[qldfrog]

Mesoblast has entered into a license and collaboration agreement with Novartis for the development, manufacture, and commercialization of remestemcel-L, with an initial focus on the treatment of acute respiratory distress syndrome (ARDS), including that associated with COVID-19. The agreement remains subject to certain closing conditions, including time to analyze the results from this COVID-19 ARDS trial

Enough to have a punt in the tipping comp.

Have an unfulfilled buy order at 1.865.
I expect it to remain unfulfilled and make me suffer as it climbs back of the canvas.

But you will suffer less when it will fall 30% in a day or 2 ,afer some bad news or the next SPP...

 

[SuperGlue]

Mesoblast has entered into a license and collaboration agreement with Novartis for the development, manufacture, and commercialization of remestemcel-L, with an initial focus on the treatment of acute respiratory distress syndrome (ARDS), including that associated with COVID-19. The agreement remains subject to certain closing conditions, including time to analyze the results from this COVID-19 ARDS trial

Enough to have a punt in the tipping comp.

Have an unfulfilled buy order at 1.865.
I expect it to remain unfulfilled and make me suffer as it climbs back of the canvas.

Is something stirring up this sleeping-little giant this morning?

Please DYOR.

 

[UMike]

One month on and the "Giant" seems to be stumbling with the latest Annual Financial Results and Operational Progress ....,

Did seem to be to much in it that surprised but it disappointed enough to see this latest drop. Expect it to recover somewhat to pick it in the Sept Comp.

 

[greggles]

One of the most brutal, terrifying 20 month market roller coaster rides I've ever seen.

 

[Knobby22]

It has a lot of irons in the fire but a lot of competition also. The company had a chance to get profitable and save a lot of kids but the recommendations to approve were ignored. Other companies based in the USA are in the space and may get ahead.
I am just keeping a very small holding now just to keep my eye on it. They still could succeed e.g. with the back treatment or the covid treatment really big but its getting trickier.

 

[UMike]

Re: MSB - Mesoblast
MSB has no income and is really a high priced biotech spekkie and I treat it as such. The trick will be to be in it for the longer term at the right time when the products are confirmed as ready to be commercialised.

Cheers
Country Lad

While I agree with most of this I am having a speccy in the Tipping thread.

Bit like tipping a bottom team for a win. But when it does it's usually a big one.

 

[Country Lad]

Re: MSB - Mesoblast

MSB has no income and is really a high priced biotech spekkie and I treat it as such. The trick will be to be in it for the longer term at the right time when the products are confirmed as ready to be commercialised.

Ha ha, that quote was 8 years ago @UMike and they now has a whole $7.4 mil income. Unfortunately this needs to be taken in the context of the $100 mil loss, so the quote is probably still valid.

 

[UMike]

Tipped it again for the November comp.

Bit like tipping a bottom team for a win. But when it does it's usually a big one.

 

[Dona Ferentes]

Yadda yadda, Novartis terminates, yadda still got our phase III yadda stems sell yadda. Down 17% .

And

For the September quarter Mesoblast reported a net loss of $US22.6 million, with cash on hand of $US116 million. It has accumulated losses of $US647.6 million since inception.

That's a bill in local money

 

[qldfrog]

Yadda yadda, Novartis terminates, yadda still got our phase III yadda stems sell yadda. Down 17% .

And


That's a bill in local money

I paid part of it!!!Aussie Aussie Aussie oi oi oi
I should join a club with @Knobby22 ;
Proud supporters of Aussie research, of Caraibes lsland mansions for executives
But I am sure if you persist.......
Note: I do not hold and never again mantra, just following the thread in case they change name
anyone detecting bitterness might be wrong

 

[Knobby22]

MSB is my pick. No one else has picked it, a very good sign.
A bit over a year ago I thought that I was going to win the yearly comp and mostly pay my house off - too greedy, ended handing most of it back. But - back treatment is exciting, kids phase 3 going ahead at last. It's risky but you have to pick a company that has a reasonable chance of doubling to win this comp.

 

[UMike]

MSB is my pick. FEB.
This time it is my chance to ride the Spec train.

Institutional investors paid $2.3 not so long ago so the potential is there...... So to is the risk.

 

[Iggy_Pop]

My pick for the stock tipping comp this month. With a recent share placement, MSB has has a dip, but I am going for a rebound after things settle down The share price has dropped close to the discounted SPP of 85 cents. I am going for a rebound


Iggy

 

[Iggy_Pop]

Trying MSB again for the stock tipping comp. The quarterly report is out today 26th May and stock price is up 5% but not sure I will catch the leaders in the May Comp. Theres always next month and there seems to be a buying trend with MSB

Iggy

 

[frugal.rock]

25.6% up for the month so far.
Well done Iggy.
Punching near 52 week highs also.